Nicolas Vantard

817 total citations
29 papers, 591 citations indexed

About

Nicolas Vantard is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Nicolas Vantard has authored 29 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Oncology. Recurrent topics in Nicolas Vantard's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Patient Safety and Medication Errors (7 papers) and Pharmaceutical studies and practices (7 papers). Nicolas Vantard is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Patient Safety and Medication Errors (7 papers) and Pharmaceutical studies and practices (7 papers). Nicolas Vantard collaborates with scholars based in France, United States and Canada. Nicolas Vantard's co-authors include Catherine Rioufol, Florence Ranchon, Vérane Schwiertz, Gilles Salles, Benoît You, Gilles Freyer, Stéphanie Parat, Émilie Hénin, Claude Dussart and V. Trillet-Lenoir and has published in prestigious journals such as PLoS ONE, European Journal of Cancer and BMC Cancer.

In The Last Decade

Nicolas Vantard

28 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Vantard France 14 201 140 134 104 73 29 591
Vérane Schwiertz France 14 170 0.8× 129 0.9× 151 1.1× 103 1.0× 74 1.0× 31 607
Florence Ranchon France 16 236 1.2× 146 1.0× 195 1.5× 132 1.3× 92 1.3× 58 812
B. Gourieux France 12 217 1.1× 90 0.6× 113 0.8× 78 0.8× 46 0.6× 58 503
Sylvia Bartel United States 13 251 1.2× 180 1.3× 208 1.6× 205 2.0× 51 0.7× 20 767
John Valgus United States 14 252 1.3× 52 0.4× 88 0.7× 174 1.7× 92 1.3× 36 643
Mikaël Daouphars France 10 91 0.5× 27 0.2× 107 0.8× 183 1.8× 74 1.0× 23 626
Nancy A. Nickman United States 14 169 0.8× 99 0.7× 33 0.2× 28 0.3× 60 0.8× 56 494
William N. Kelly United States 13 274 1.4× 156 1.1× 29 0.2× 140 1.3× 61 0.8× 47 671
Carlton K.K. Lee United States 16 96 0.5× 98 0.7× 103 0.8× 164 1.6× 43 0.6× 30 845
Mónica Climente Martí Spain 10 153 0.8× 89 0.6× 45 0.3× 50 0.5× 8 0.1× 61 410

Countries citing papers authored by Nicolas Vantard

Since Specialization
Citations

This map shows the geographic impact of Nicolas Vantard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Vantard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Vantard more than expected).

Fields of papers citing papers by Nicolas Vantard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Vantard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Vantard. The network helps show where Nicolas Vantard may publish in the future.

Co-authorship network of co-authors of Nicolas Vantard

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Vantard. A scholar is included among the top collaborators of Nicolas Vantard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Vantard. Nicolas Vantard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernard, Jean, Charles‐Hervé Vacheron, Nicolas Vantard, et al.. (2023). Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: A retrospective study. Journal of Critical Care. 78. 154399–154399. 2 indexed citations
2.
Rioufol, Catherine, Nicolas Vantard, Alexandre Teixeira, et al.. (2022). Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer. Journal of Oncology Pharmacy Practice. 29(3). 750–754.
3.
Baudouin, Anne, et al.. (2021). Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases. Journal of Cancer Research and Clinical Oncology. 148(3). 707–718. 30 indexed citations
4.
5.
Ranchon, Florence, Laure Huot, Isabelle Carpentier, et al.. (2020). Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects. PLoS ONE. 15(12). e0243309–e0243309. 4 indexed citations
6.
Alyami, Mohammad, Frédéric Mercier, Nicolas Vantard, et al.. (2018). No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis. Anticancer Research. 38(12). 6869–6875. 14 indexed citations
7.
Fargier, Emilie, Nicolas Vantard, Florence Ranchon, et al.. (2017). Évolution du remboursement des anticancéreux inscrits sur la liste en sus : impact financier au sein d’un centre hospitalo-universitaire. Bulletin du Cancer. 104(6). 538–551. 2 indexed citations
8.
Fargier, Emilie, Florence Ranchon, Laure Huot, et al.. (2017). SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma. Annals of Hematology. 97(1). 123–131. 16 indexed citations
9.
Schwiertz, Vérane, Céline Alloux, Nicolas Vantard, et al.. (2016). SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study. International Journal for Quality in Health Care. 28(3). 311–315. 7 indexed citations
10.
Ranchon, Florence, Nicolas Vantard, Vérane Schwiertz, et al.. (2016). Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients. Hematological Oncology. 35(4). 584–590. 28 indexed citations
11.
Ranchon, Florence, Lila Gilis, Vérane Schwiertz, et al.. (2015). Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(4). 723–730. 58 indexed citations
12.
Ranchon, Florence, Audrey Nosbaum, Benoît You, et al.. (2014). Hypersensitivity to oxaliplatin: clinical features and risk factors. BMC Pharmacology and Toxicology. 15(1). 1–1. 70 indexed citations
13.
Rioufol, Catherine, Florence Ranchon, Vérane Schwiertz, et al.. (2014). Administration of Anticancer Drugs: Exposure in Hospital Nurses. Clinical Therapeutics. 36(3). 401–407. 12 indexed citations
14.
Ranchon, Florence, Benoît You, Gilles Salles, et al.. (2013). Improving Cancer Patient Care with Combined Medication Error Reviews and Morbidity and Mortality Conferences. Chemotherapy. 59(5). 330–337. 8 indexed citations
15.
Ranchon, Florence, Benoît You, Gilles Salles, et al.. (2012). Predictors of prescription errors involving anticancer chemotherapy agents. European Journal of Cancer. 48(8). 1192–1199. 32 indexed citations
16.
Ranchon, Florence, Gilles Salles, Hans-Martin Späth, et al.. (2011). Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer. 11(1). 478–478. 93 indexed citations
17.
Ranchon, Florence, Nicolas Vantard, Aurore Gouraud, et al.. (2011). Suspicion of Drug-Drug Interaction between High-Dose Methotrexate and Proton Pump Inhibitors: A Case Report – Should the Practice Be Changed?. Chemotherapy. 57(3). 225–229. 15 indexed citations
18.
Cabelguenne, Delphine, et al.. (2010). Problèmes médicamenteux les plus fréquemment détectés par l’analyse pharmacothérapeutique des prescriptions dans un centre hospitalier universitaire. La Revue de Médecine Interne. 31(12). 804–811. 30 indexed citations
19.
Vantard, Nicolas, et al.. (2009). Injection intraveineuse accidentelle de chlorure de potassium : facteurs contributifs et obstacles à la réduction du risque. Annales Françaises d Anesthésie et de Réanimation. 28(5). 436–441. 5 indexed citations
20.
Vantard, Nicolas, et al.. (2006). Consultation de pharmacie et niveau de connaissance des patients hospitalisés traits par des médicaments anti-vitamine K. Annales Pharmaceutiques Françaises. 64(5). 344–349. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vérane Schwiertz Breakdown of academic impact, for papers by Florence Ranchon Breakdown of academic impact, for papers by B. Gourieux Breakdown of academic impact, for papers by Sylvia Bartel Breakdown of academic impact, for papers by John Valgus Breakdown of academic impact, for papers by Mikaël Daouphars Breakdown of academic impact, for papers by Nancy A. Nickman Breakdown of academic impact, for papers by William N. Kelly Breakdown of academic impact, for papers by Carlton K.K. Lee Breakdown of academic impact, for papers by Mónica Climente Martí
Rankless by CCL
2026